bearish

Aier Eye Hospital Group

Aier Eye Hospital (300015.CH) 22H1 - More Downside Ahead; The Long Logic Doesn't Exist

Aier has hit a growth ceiling.As endogenous demand steps downward,performance will further decline.The bottom of healthcare sector will appear after Aier’s valuation collapse. Beware of valuation trap

Equity Bottom-Up
263 Views, 20 Sep 2022 09:11
SUMMARY(Sign Up to Access)
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
  • Unlimited Research Summaries
  • Personalised Alerts
  • Custom Watchlists
  • Company Data & News
  • Events & Webinars
or
Trusted by:
Bloomberg
Societe Generale
SGX
Sequoia
Interactive Broker
Refinitiv
Already have an account? Sign In Now
Full Insight
(Paid Plans Only)
Discussions
(Paid Plans Only)
WHAT’S TRENDING
Insights
  • Trending
  • Latest
Logo
Top Quartile
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
ChinaHealth CareEquity Bottom-UpThematic (Sector/Industry)
Price Chart(Sign Up to Access)
analytics-chart
  • Pine Care Group (1989.HK) - Hard to Make Profits Due to Industry Characteristics; Here Is What to Do
    24 Sep 2022
  • Angelalign Technology (6699.HK) 22H1 - Still “Bubble” in Valuation; The Era of High Margin Is Over
    22 Sep 2022
  • Remegen Co Ltd (9995.HK) 22H1 - Mr. Market's "Misjudgment" Brings Opportunities to Make Money
    21 Sep 2022
  • Aier Eye Hospital (300015.CH) 22H1 - More Downside Ahead; The Long Logic Doesn't Exist
    20 Sep 2022
  • Aier Eye Hospital Group (300015.CH) 2021/2022Q1 Results - Overvaluation and a Risky Outlook
    18 May 2022
  • Hygeia Healthcare Group (6078.HK) 2021 Results - Solid Business Logic Comes with Policy Risk
    20 Apr 2022
  • Topchoice Medical (600763.CH) - The Logic Changes
    15 Mar 2022
  • Aier Eye Hospital Group (300015.CH) - More than Just Bribery Scandal
    20 Jan 2022
  • Aier Eye Hospital Group (300015.CH) - The Concerns Behind the High Growth Momentum
    28 Sep 2021
x